◎reply_notice
thematicgalaxiangame: China's stock market welcomes rebound, A-share valuation discounts will narrow
On May 22, it was reported that Huaxi Biotech rose by more than 14%, Yuexin Health rose by daily limit, Langzi shares were close to daily limit, and Blonde Rabi, Ha Sanlian and Aimei rose by more than 5%.
On the news front, it is reported that the Guangdong Province Health Commission recently issued an adjustment notice for medical cosmetic surgery projects, adding injection items such as hyaluronic acid to the first-level cosmetic surgery projects.
Unless otherwise specified, the copyright of this article belongs to feature buy. Please indicate the source when reprinting.
Category: Health
◎reply_notice